426219-23-0

Basic information

• Product Name: (R)-6-(7-hydroxy-6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-7-yl)-N-methyl-2-naphthamide
• Synonyms: (R)-6-(7-hydroxy-6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-7-yl)-N-methyl-2-naphthamide;6-(7-hydroxy-6,7-dihydro-5H-pyrrolo[1,2-c]iMidazol-7-yl)-N-Methyl-2-naphthaMide
• CAS NO: 426219-23-0
• Molecular Formula: C18H17N3O2
• Molecular Weight: 307.34648
• Mol File: 426219-23-0.mol
• Article Data: 4

Chemical Properties

• Appearance: /
• CAS DataBase Reference: (R)-6-(7-hydroxy-6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-7-yl)-N-methyl-2-naphthamide(CAS DataBase Reference)
• NIST Chemistry Reference: (R)-6-(7-hydroxy-6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-7-yl)-N-methyl-2-naphthamide(426219-23-0)
• EPA Substance Registry System: (R)-6-(7-hydroxy-6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-7-yl)-N-methyl-2-naphthamide(426219-23-0)

Safety Data

• Hazardous Substances Data: 426219-23-0(Hazardous Substances Data)

Usage

General Description

The chemical "(R)-6-(7-hydroxy-6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-7-yl)-N-methyl-2-naphthamide" is a complex organic compound with a long chemical name. (R)-6-(7-hydroxy-6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-7-yl)-N-methyl-2-naphthamide is a derivative of 2-naphthamide and contains a methyl group and a pyrroloimidazolyl moiety. It has a stereoisomeric configuration of (R) and has a hydroxyl group attached to the pyrroloimidazolyl ring. The chemical structure of this compound potentially makes it suitable for various pharmaceutical or biological applications, and it may possess specific therapeutic properties due to its unique structural features. Additionally, further research and studies may be necessary to fully understand its potential uses and effects in different applications.

Upstream product

• 426219-43-4 5,6-dihydro-7H-pyrrolo[1,2-c]imidazol-7-one 
• 566200-77-9 6-[1,3-dihydroxy-1-(1-trityl-1H-imidazol-4-yl)propyl]-N-methyl-2-naphthamide 
• 109-72-8 n-butyllithium 
• 1346155-60-9 6-(7-hydroxy-6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-7-yl)-N,N-diisopropyl-2-naphthamide 
• 426219-35-4 6-bromo-N-methyl-2-naphthamide 
• 392-83-6 o-trifluoromethylphenyl bromide 
• 426219-46-7 6-bromo-N,N-diisopropyl-2-naphthamide 
• 1346155-54-1 N,N-diisopropyl-6-[1-hydroxy-1-(1-trityl-1H-imidazol-4-yl)methyl]-2-naphthamide 
• 426219-47-8 N,N-diisopropyl-6-[(1-trityl-1H-imidazol-4-yl)carbonyl]-2-naphthamide 
• 74-89-5 methylamine 
• 1346155-45-0 3-bromo-1-(1H-imidazol-4-yl)-1-propanone hydrobromide 
• 57531-35-8 C₆H₆N₂O 
• 5773-80-8 6-bromo-2-naphthoic acid 
• 87700-60-5 6-bromonaphthalene-2-carbonyl chloride 

Downstream Products

• 566939-85-3 Orteronel 
• 752243-39-3 6-(7-hydroxy-6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-7-yl)-N-methylnaphthalene-2-carboxamide 
• 426219-53-6 2C₁₀H₁₁NO₅*C₁₈H₁₇N₃O₂ 

Relevant articles and documents

1,1-Diarylalkenes as anticancer agents: Dual inhibitors of tubulin polymerization and phosphodiesterase 4

A series of 1,1-diarylalkene derivatives were prepared to optimize the properties of CC-5079 (1), a dual inhibitor of tubulin polymerization and phosphodiesterase 4 (PDE4). By using the 3-ethoxy-4-methoxyphenyl PDE4 pharmacophore as one of the aromatic ri

Novel imidazole derivatives, production method thereof and use thereof

The present invention provides a compound having a steroid C17,20-lyase-inhibitory activity and useful for the therapy and prophylaxis of tumor such as prostatism, breast cancer and the like, and a method for efficiently separating an optically active compound of this compound from a mixture of optical isomers thereof, a compound of the formula: wherein each symbol is as defined in the specification, a salt thereof or a prodrug thereof, and a method for obtaining an optically active compound by optically resolving a mixture of optical isomers by the use of a resolving agent such as tartranilic acid and the like.